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Role of osmolality in blood pressure stability after dialysis and
ultrafiltration. To clarify the mechanisms involved in the stability
of blood pressure during ultrafiltration (UF) alone versus regular
dialysis, this study systematically examined the importance of
changes in serum potassium, osmolality, and plasma norepineph-
rine during several dialysis maneuvers. Six stable, normotensive
chronic dialysis patients were subjected to a uniform 2 to 3%
decrease in body weight during the 2 hours of each dialysis ma-
neuver. Supine to upright mean blood pressure (MBP) decreased
(90 to 75 mm Hg, P <0.05), and three patients became sympto-
matic after weight loss during regular dialysis, but orthostatic
blood pressure was stable (89 to 86 mm Hg, NS) and the patients
were asymptomatic after UF and weight loss. isokalemic regular
dialysis did not afford hemodynamic stability, as orthostatic
MBP declined (85 to 56 mm Hg, P < 0.02), and four of the pa-
tients again were symptomatic after standing. A continuous hy-
pertonic mannitol (25%) infusion during the 2-hour dialysis, how-
ever, kept osmolality from decreasing and was associated with a
stable orthostatic MBP (89 to 83 mm Hg, NS). A continuous in-
fusion of isotonic mannitol (5%) given in a volume five times that
of the hypertonic mannitol failed to prevent orthostatic hypoten-
sion (89 to 60 mm Hg, P < 0.005). Plasma norepinephrine con-
centrations were high in these patients and increased only mod-
estly after weight loss. These results implicate constant plasma
osmolality as a critical protective factor of blood pressure during
UF and further demonstrate that changes in blood pressure may
be dissociated from changes in both serum potassium and plasma
norepinephrine concentration.
Role de l'osmolalité dans Ia stabilité de Ia pression artérielle
après dialyse et ultrafiltration. Afin de clarifier les mécanismes
impliques dans Ia stabiité de la pression artérielle au cours de
l'ultraflltration (UF) seule par comparaison avec la dialyse habit-
uelle ce travail évalue systématiquement l'importance des modi-
fications de la kaliémie, de l'osmolalité et de la norépinéphrine
plasmatique au cours de plusieurs tactiques de dialyse. Six sujets
stables, normotendus, en hemodialyse chronique ont subi une
diminution de poids corporel de 2 3% au cours des 2 heures de
chaque tactique de dialyse. La pression artérielle moyenne a di-
minué de la position couchée ala position debout (de 90 75 mm
Hg, P < 0,05) et trois patients sont devenus symptomatiques
après Ia perte de poids au cours de la dialyse habituelle. Par
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contre Ia pression artérielle orthostatique a eté stable (89 a 86 mm
Hg, NS) et les malades ont été asymptomatiques après UF. La dia-
lyse habituelle isokaliemique n'a pas déterminé de stabilité
hémodynamique, Ia pression artérielle moyenne orthostatique a
diminué (85 56 mm Hg, P < 0,02) et quatre malades ont été a
nouveau symptomatiques quand ils se sont levés. Cependant
quand une perfusion continue de mannitol hypertonique (25%)
pendant les deux heures de Ia dialyse a empêchd la baisse de
l'osmolalité Ia pression arténelle moyenne orthostatique a été
stable (89 a 83 mm Hg, NS). Une perfusion continue de mannitol
isotonique (5%) apportant un volume cinq fois celui du mannitol
hypertonique n'a pas empêché l'hypotention orthostatique (89 a
60 mm Hg, P < 0,005). Les concentrations plasmatiques de noré-
pinephrine étaient élevées chez ces malades et n'ont que peu
augmente apres la perte de poids. Ces résultats impliquent
qu'une osmolalité plasmatique constante est un facteur pro-
tecteur critique pour la pression arténelle au cours de UF et ils
démontrent, de plus, que les modifications de Ia pression artér-
idle peuvent étre dissociées des modifications du potassium
plasmatique et de Ia concentration de norépinéphrine.
Hypotension occurring during weight removal in
patients on hemodialysis is a frequent and per-
plexing clinical problem, and is a significant cause
of morbidity in dialyzed patients. Several possible
mechanisms by which hemodialysis may provoke
hypotension include rapid volume depletion, and
sudden declines in either serum potassium, plasma
norepinephrine, or plasma osmolality. Autonomic
neuropathy is frequent in dialysis patients [1, 2],
and hypokalemia may further impair protective cir-
culatory reflexes needed to avoid hypotension [3,
4]. Similarly, a decline in norepinephrine concentra-
tion is reported to occur during dialysis [5], an ef-
fect that could impede a normal maximal increase in
peripheral vascular resistance in response to a fall
in blood pressure. Finally, a decline in osmolality
may compound hypotension by enhancing hypovo-
lemia or via an effect on resistance vessels [6, 7].
Dialysis ultrafiltration is a process in which hy-
drostatic pressure exerted across a dialysis mem-
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brane is utilized to cause fluid removal in a manner
similar to regular hemodialysis, except that no
dialysate is allowed to circulate during the proce-
dure [5]. This maneuver results in improved toler-
ance to weight removal in dialysis patients [7, 8].
Despite these observations, the exact mechanisms
responsible for this blood pressure protection re-
main uncertain. In contrast to regular hemodialysis,
ultrafiltration alone causes no changes in serum po-
tassium or osmolality, but the degree to which these
factors influence the stability of blood pressure dur-
ing rapid weight loss is unclear. Moreover, the im-
portance of circulating plasma norepinephrine con-
centration in ultrafiltration is still speculative.
Therefore, in an effort to determine why blood
pressure remains stable during fluid removal in ul-
trafiltration, we systematically studied six stable
chronic hemodialysis patients during five different
dialysis maneuvers: regular dialysis, ultrafiltration
alone, isokalemic regular dialysis, continuous hyper-
tonic mannitol infusion, and finally, continuous iso-
tonic mannitol infusion. The results implicate the
maintenance of a constant plasma osmolality as the
primary blood pressure protective factor during ul-
trafiltration, and further suggest that this protective
effect is independent of changes in serum potassium
or plasma norepinephrine concentration.
Methods
Six stable hemodialysis patients with their native
kidneys were used in each aspect of the study. Each
patient was normotensive and took no anti-
hypertensive medications for at least 6 months prior
to study. Interdialytic weight gains did not exceed
4% of body weight in these patients. Informed con-
sent was obtained from each patient prior to entry
into the study. All patients were male with a mean
age of 59 (sEM) 2 years and had been on chronic
dialysis three times per week for a mean of 40 9
months. The etiology of renal failure in the patients
was polycystic kidney disease in three, analgesic
nephropathy in one, and nephrosclerosis in two.
The six study patients were selected from a dialysis
population of 42 patients on the basis of normal re-
sponses to both an amyl nitrate inhalation test [10]
and a standard Valsalva maneuver [11]. Forced ex-
piration against 40 mm Hg for 10 to 12 sec was used
as the standard strain. An insufficient autonomic re-
sponse was defined if both the arterial pressure
overshoot and bradycardia were absent after re-
lease of the strain. The results of these studies are
depicted in Table 1. Thus, these patients were spe-
cially selected in order to exclude autonomic in-







! 6 6 1.00 + +
2 20 30 0.67 + +
3 18 19 0.95 + +
4 24 23 1.04 + +
5 20 23 0.87 + +
6 15 !5 1.00 + +
Mean 17 19 0.92
SEM 2.5 3.3 0.06
a HR denotes increase in heart rate.
LBP denotes decrease in mean blood pressure.
sufficiency and hypertensive medications as vari-
ables that could influence the hemodynamic re-
sponses to the dialysis protocols.
For each of the five maneuvers listed below, the
patients were studied on their regular beginning-of-
the-week dialysis day (either Monday or Tuesday).
In each protocol, the same dialyzer (Travenol Hol-
low Fiber 1.3 m2; Travenol Laboratories, Deerfield,
Illinois) and delivery system (Drake-Willock single
patient proportioning unit; Drake-Willock, Inc.,
Portland, Oregon) was used.
An identical protocol was followed during each
dialysis maneuver. The protocol was as follows: Af-
ter being weighed, the patients remained recumbent
for 15 mm. after insertion of needles for standard
dialysis. Supine blood pressure, heart rate, and
blood samples (plasma electrolytes, osmolality, and
plasma norepinephrine) were obtained. The pa-
tients then stood for 5 to 7 mm, and blood pressure,
heart-rate, and blood samples for norepinephrine
were again obtained. Following these premaneuver
measurements, the patients remained recumbent
for 2 hours, during which time 2 to 3% of body
weight was removed by each dialysis maneuver. Af-
ter 2 hours of the dialysis procedure, the blood
pump was stopped, and blood pressure, heart rate,
and blood work (electrolytes, osmolality, and nor-
epinephrine) were again performed in the supine po-
sition. The patients then stood, and weight, blood
pressure, and heart rate were noted. Symptoms of
postural hypotension were also recorded, as blood
(plasma norepinephrine only) was again sampled.
The patients did not eat or drink during the 2-hour
study period. After completion of each dialysis pro-
tocol, a regular dialysis was resumed for 3 to 4
hours as per the patient's usual routine.
Five different maneuvers were performed as fol-
lows:
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I. Regular dialysis. Standard hemodialysis with
sufficient negative pressure to reduce body weight
by 2.5% was performed.
II. Ultra Itration alone. The same protocol as
listed above was used except that the dialysis ma-
chine was placed in bypass, and dialysate was not
circulated through the dialyzer.
III. Isokalemic dialysis. Each patient had a
serum potassium measured during the predialysis
blood sampling, and sufficient potassium was added
to the dialysate mixture to increase the concentra-
tion to that of the patient's serum. Constant elec-
trocardiographic monitoring was performed during
the 2 hours of dialysis, and serum potassium was
sampled every 30 mm. Following the completion of
the 2-hour protocol, 3 to 4 hours of regular dialysis
with a low potassium bath was undertaken.
IV. Hypertonic mannitol. Twenty-five percent
hypertonic mannitol in a dose of 0.16 g/kg/hr was
evenly infused with a Sage pump (Sage Instruments
Inc., White Plains, New York) into the venous re-
turn line throughout the 2-hour protocol period.
This dose will yield a constant plasma osmolality
during a 6-hour dialysis procedure [12]. Plasma for
osmolality was sampled every 15 mm. to verify that
osmolality did not vary during the infusion.
V. Isotonic mannitol. In these studies, 5% iso-
tonic mannitol was evenly infused into the venous
return line over the 2-hour protocol period. The vol-
ume of isotonic mannitol infused was exactly five
times the volume infused during the hypertonic
mannitol study, so that although the concentration
of mannitol given in the two protocols (IV and V)
was different, the absolute amount was the same.
No patients experienced any deleterious effects
from any aspect of the study, although (as men-
tioned in the Results sections) dizziness and nausea
occurred in some patients after standing and weight
loss.
Electrolyte determinations were performed by
flame photometry, and urea nitrogen, plasma pro-
teins, and creatinine were done by an autoanalyzer.
Plasma osmolality was measured by freezing-point
depression (Advanced Instruments, Inc., New
Highlands, Massachusetts). All samples for cate-
cholamines measurements were collected on ice in
chilled tubes containing glutathione, immediately
separated by cold centrifugation, and frozen at
—70° C. Plasma catecholamines were analyzed by a
radioenzymatic methodology previously described
[13]. Briefly, this method involves enzymetric o-
methylation of the catechol hydroxy and separation
of metabolites by thin layer chromatography and
scintillation counting. The mean normal supine val-
ue for norepinephrine with this methodology in 42
normotensive subjects was 172 10 pg/mI; the
mean for norepinephrine value after standing for 5
mm. was 377 21 pg/ml.
Statistics were performed using Student's t test
when comparing pre to post or supine to upright
values in any given patient. Analysis of variance
[14] was used when results from different groups of
dialysis protocols were compared. Data are pre-
sented as the means SEM, and aP value of < 0.05
was considered significant.
Results
Changes in body weight during the dialysis ma-
neuvers (Table 2). Body weight declined com-
parably and significantly during the 2 hours of each
of the dialysis maneuvers. Pre and post maneuver
weights were also similar for each of the maneu-
vers, and the percent decrease in body weight in
each maneuver was also statistically similar, with a
range of —2.13% (isotonic mannitol) to —3.2% (ul-
trafiltration only). Thus, the magnitude of weight
loss was similar in each of the procedures.
Changes in blood chemistries during dialysis ma-
neuvers (Table 3 and Fig. 1). Changes in plasma os-
molality, urea nitrogen, creatinine, and serum po-
tassium and sodium are depicted in Table 3. During
regular dialysis a significant 7% decrease in Os-
molality (from 308 6 to 288 7 mosmlkg H20, P
<0.001) and serum potassium (from 4.9 to 0.3 to 3.9
0.2 mEq/liter, P <0.005) occurred in the 2 hours
of the protocol. In contrast, ultrafiltration induced
no significant alteration in either osmolality (309 6








I. Regulardialysis 79.3 6.0 77.3 6 <.001 2.5%
II. Ultrafiltration only 79.6 6.0 77.0 6 <.001 3.2%
HI. Isokalemic dialysis 79.8 6.0 77.9 6 <.005 2.6%
IV. Hypertonic mannitol 79.7 7.0 77.7 6 <.01 2.6%
V. Isotonic mannitol 79.8 7.0 78.1 7 <.001 2.13%
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Table 3. Changes in blood chemistries during dialysis maneuvera
Regular dialysis
After
Ultrafiltration Isokalemic dialysis Hypertonic mannitol Isotonic mannitol
After After After After
Pre P 2hr Pre P 2hr Pre P 2hr Pre P 2hr Pre P 2hr
Plasma osmolality, 308 288 309 306 308 296 301 298 306 290
mOsmtkgH2O ±6 ±7 ±6 ±6 ±7 ±5 ±6 ±5 ±5 ±3
<0.001 NS <0.005 NS <0005
Serumpotassium, 4.9 3.9 5.0 5.2 5.1 5.0 5.3 4.0 5.2 4.0
mEq/liter ±0.3 ±0.2 ±0.2 ±0.3 ±0.3 ±0.3 ±0.2 ±0.3 ±0.3 ±0.2
<0.005 NS NS <0.001 <0.001
Serum sodium, 139 137 138 136 137 132 131 132 137 134
mEqiliter ±2 ±2 ±2 ±2 ±2 ±2 ±3 ±3 ±3 ±2





















<0.02 NS <0.001 <0.001 <0.001
Serumcreatinine, 13.6 10.8 14.7 14.10 17 12 17 11 15.1 10
mg/dl ±1.0 ±1.2 ±1.7 ±1.3 ±1 ±1 ±1 ±1 ±1.1 ±1
<0.01 NS <0.005 <0.001 <0.001
a Values are the means ± SEM. Pre is predialysis, and after 2 hr means at conclusion of weight loss.
to 306 ± 6 mOsmlkg H20, NS) or potassium (5.0 ±
0.2 to 5.2 ± 0.3 mEq/liter, NS).
The possibility that this maintenance of potas-
sium and osmolality that occurred in ultrafiltration
was responsible for improved blood pressure during
rapid weight loss (vide infra) was further investi-
gated in the next two series of studies. In the first,
dialysate potassium concentration was increased to
that of the predialysis serum. In these studies
(isokalemic dialysis, Table 3), serum potassium was
held constant (5.1 ± 0.3 to 5.0 ± 0.3 mEq/liter, NS)
during the 2-hour dialysis as plasma osmolality was
allowed to decrease 4% (from 308 ± 7 to 296 ± 5
mOsm/kg H20, P <0.005). To isolate the effect of
constant osmolality as a potential blood pressure
protective factor during dialysis, we infused hyper-
tonic mannitol (25%; 0.16 glkg/hr) during the 2
hours of dialysis; plasma osmolality was checked
every 15 mm to detect any fluctuations in osmolality
(Fig. 1). In these studies (hypertonic mannitol),
plasma osmolality was maintained constant during










Regular I sokalemic Isotonic Ultrafiltration Hypertonic
dialysis dialysis mann itol mann itol
Fig. 1. Pre and post maneuver plasma osmolality. A significant decrease in plasma osmolality occurred after 2 hours of regular dialysis,
isokalemic dialysis, and isotonic mannitol dialysis. Plasma osmolality was stable after 2 hours of ultrafiltration and hypertonic mannitol.
Open bars denote premaneuver; closed bars, after 2 hours.
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Table 4. Changes in blood pressure and heart rate during each dialysis maneuvers






Sup P Upr Sup P Upr Sup P UprSup P Upr
92 97 88 91 88
Premaneuver
85 89 89.4 92 95
±7 ±5 ±4 ±5 ±3 ±3 ±3 ±2.7 ±4 ±3
NS NS NS NS NS
90 75 89 86 85
After2 hr
56 89 83 87 69
±6 ±13 ±5 ±7 ±5 ±10 ±3 ±6 ±6 ±6
<0.05 NS <0.02 NS <0.005
Values are means ± SEM. Abbreviations used are: RD, regular dialysis; UF, ultrafiltration; ISOK+, isokalemic dialysis; HMAN,
hypertonic mannitol; IMAN, isotonic mannitol; Sup, supine; Upr, upright.
H20, NS) as plasma potassium was allowed to de-
crease (5.3 ± 0.2 to 4.0 ± 0.3 mEq/liter, P < 0.001).
The insignificant decreases in plasma osmolality in
the hypertonic mannitol group and the ultrafiltra-
tion group (a 1% decrease in plasma osmolality)
were significantly less than that observed either in
the regular dialysis group (—7%, P < 0.05) or the
isokalemic group (—4%, P <0.05).
In the final dialysis maneuver, studies in which
isotonic mannitol (5%) was infused evenly over the
2-hour protocol were performed. The volume of iso-
tonic mannitol infused was five times that infused
during the hypertonic mannitol studies for each pa-
tient, so that each patient received the identical
amount of mannitol that was previously infused, but
at a different concentration. In this group of experi-
ments, plasma osmolality declined 5.2% (306 ± 5 to
290 ± 3 mOsm/kg H20, P <0.005) and serum potas-
sium (5.2 ± 0.3 to 4.0 ± 0.2 mEq/liter, P < 0.001)
again fell during the 2 hours of dialysis and the con-
stant infusion.
Changes in blood pressure and heart rate during
each dialysis maneuver (Table 4 and Fig. 2). Supine
and upright blood pressures were comparable prior
to each dialysis protocol, as no clear directional
changes in blood pressure were observed with as-
sumption of the upright position. Following weight











Regular I sokalemic Isotonic Ultrafiltration Hypertonic
dialysis dialysis mannitol mann itol
Fig. 2. Orthostatic blood pressure change after weight loss. Orthostatic mean blood pressure decreased significantly following regular
dialysis, isokalemic dialysis, and isotonic mannitol dialysis. No significant decrease in mean blood pressure occurred after ultrafiltration
and hypertonic mannitol dialysis. Open bars denote supine position; closed bars, upright position.
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Table 4. (continued)
Heart rate, beats/mm
RD UF ISOK+ HMAN IMAN
Sup P Upr Sup P Upr Sup P Upr Sup P Upr Sup P Upr
86 93 87 93 85
Premaneuver
90 78 93 79 88
±6 ±5 ±6 ±6 ±5 ±5 ±6 ±8 ±5 ±6
<0.05 <0.05 <0.05 <0.005 <0.005
88 107 77 93 96
After2 hr
110 83 102 83 105
±6 ±6 ±6 ±9 ±5 ±6 ±5 ±6 ±4 ±5
<0.05 <0.05 <0.025 <0.001 <0.01
ferent than supine or upright premaneuver pres-
sure. On assumption of the upright posture follow-
ing weight loss, however, impressive differences in
blood pressure were noted. Mean blood pressure
fell from 90 ± 6 to 75 ± 13 mm Hg (P <0.05) in the
regular dialysis group, and three of the patients be-
came symptomatic (dizziness in two and nausea and
dizziness in one) when upright. In striking contrast,
after ultrafiltration alone and a body weight loss of
3.2%, mean blood pressure was well maintained (89
± 5 supine vs. 86 ± 7 mm Hg upright, NS). More-
over, none of the latter patients were symptomatic
when upright.
The possibility that isokalemia during ultrafiltra-
tion contributed to this protective effect on ortho-
static pressure was next examined in studies in
which the serum potassium was maintained con-
stant and osmolality allowed to fall (isokalemic dial-
ysis). After the 2 hours of dialysis and a 2.6% body
weight loss, however, orthostatic mean blood pres-
sure fell markedly from 85 ± 5 to 56 ± 10 mm Hg (P
< 0.02). Moreover, four of the six patients again
became symptomatic on standing. This result sug-
gested that factors other than isokalemia were re-
sponsible for the blood pressure protection ob-
served during ultrafiltration.
In the next series of studies, hypertonic mannitol
(25%) was infused to achieve constant plasma os-
molality. In contrast to the isokalemic and regular
dialysis maneuvers, mean blood pressure did not
fall after a 2.6% weight loss and standing (89 ± 3 to
83 ± 6 mm Hg, MS). The maintenance of constant
plasma osmolality or the addition of a constant in-
fusion of volume could have explained this result.
Therefore, in the final series of studies, isotonic
mannitol (5%) was infused to provide the same
amount of mannitol as infused during the hyper-
tonic mannitol studies. In this final group of experi-
ments, plasma osmolality was thus allowed to de-
cline 5.2%. After a 2.13% weight loss and the iso-
tonic mannitol infusion, mean blood pressure again
fell from 87 ± 6 to 69 ± 6 mm Hg, P < 0.005. To
estimate changes in plasma volume during the hy-
pertonic and isotonic mannitol infusion studies, we
made comparisons of pre and post maneuver hema-
tocrits and plasma proteins. A comparable increase
in hematocrit occurred after both hypertonic manni-
tol (from 27.2 ± 2 to 29.2 ± 2%, P < 0.025) and
isotonic mannitol (from 28 ± 3 to 29.3 ± 2.0%, P <
0.02) studies. Similarly, the increases in plasma pro-
teins following hypertonic mannitol (7.0 ± 0.8 to 7.5
± 0.2 mgldl, P <0.05) and isotonic mannitol (6.9 ±
0.2 to 7.6 ± 0.14 mg/dl, P <0.005) were also com-
parable. Thus, the decrement in estimated plasma
volume was comparable during these two protocols.
In all protocols, standing resulted in a significant
increase in heart rate both before and after the dial-
ysis maneuvers.
Changes in plasma norepinephrine (Table 5).
Baseline plasma norepinephrine concentrations
were noted to be high in the dialysis patients, a find-
ing noted in previous investigations [15, 16]. During
regular dialysis and ultrafiltration, plasma norepi-
nephrine moderately increased after weight loss and
orthostatic challenge. No significant differences in
post maneuver upright norepinephrine concentra-
tions, however, were noted in the two groups (regu-
lar dialysis, 991 ± 237, vs. ultrafiltration, 1032 ±
218 pg/mI, NS), and the magnitude of increase was
similar in both groups. During the isokalemic dial-
ysis maneuver, norepinephrine again increased sig-
nificantly on standing (from 512 ± 155 to 675 ± 162
pg/ml), p < 0.005), but mean blood pressure fell
(from 85 ± 5 to 56 ± 10, P <0.02). This result clear-
ly suggested that although baseline levels are high,
directional changes in plasma norepinephrine of the
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Ultrafiltration Isokalemic dialysis Hypertonic mannitol Isotonic mannitol
Sup P Upr Sup P Upr Sup P Upr Sup P Upr
Prernaneuver norepinephrine, pg/mi
687 756 736 890 602 624 688 630 766 1070
±78 ±83 ±93 ±141 ±110 ±98 ±96 ±120 ±174 ±226
NS NS NS NS <0.02
627 991 814
2-hour norepinephrine, pg/mi
1032 512 675 711 757 625 785
±88 ±237 ±158 ±218 ±63 ±66 ±134 ±173 ±108 ±119
NS <0.025 <0.005 NS <0.001
a Values are the means ± 5EM. Sup denotes supine position; Upr, upright position.
magnitude observed in this study do not prevent de-
creases in mean blood pressure. In the hypertonic
mannitol dialysis, mean pressure was maintained
after standing and weight loss (89 ± 3 to 83 ± 6 mm
Hg, NS), and no change occurred in plasma norepi-
nephrine (711 ± 134 to 757 ± 173 pg/mi, NS). Final-
ly, following the isotonic mannitol infusion dialysis,
assumption of the upright posture produced a fall in
mean blood pressure (87 ± 6 to 69 ± 6 mm Hg, P <
0.005) as plasma norepinephrine again increased
modestly (625 ± 108 to 785 ± 119 pg/mi, P <0.001).
No consistant abnormalities of epinephrine or dopa-
mine were observed in any of the protocols.
Discussion
There are many potential reasons for hypotension
to occur during hemodialysis. Rapid weight remov-
al with depletion of the circulating plasma volume is
of primary importance in many instances of dialysis
hypotension [17]. Autonomic insufficiency, how-
ever, is a common finding in dialyzed patients and
may prohibit the normal function of protective re-
flexes that are activated during hypotensive stress
[1, 2, 10, 18]. Further, hypokalemia is a therapeutic
goal of dialysis but potentially may exacerbate auto-
nomic insufficiency [3, 4], thereby compounding
any tendency to hypotension. Moreover, a fail in
plasma osmolality also occurs routinely during reg-
ular dialysis, favoring a greater intracellular move-
ment of water, thus compounding hypovolemia. Fi-
nally, the importance of catecholamines in the
stress response to hypotension induced in dialysis is
unclear. Plasma norepinephrine concentrations
have been previously noted to be high in dialysis
patients [15], but questions as to the ability (and the
importance) of catecholamines to increase during
dialysis remain unsettled [5].
Ultrafiltration is a dialysis technique, first de-
scribed by Alwall and Herner [19], that has been
associated with maintenance of blood pressure de-
spite sudden, profound weight loss, even in patients
with a tendancy to develop hypotension on regular
dialysis [6, 7]. This procedure differs from regular
dialysis in that dialysate flow is absent and, thus,
only ultrafiltration of the plasma occurs; plasma os-
molality remains constant during the weight loss be-
cause dialysis is not occurring. A series of recent
investigations performed by Bergstrom and Wehle
et al have shown ultrafiltration to be a practical
method of fluid removal in dialysis patients prone to
hypotension [6, 8]. These investigators have pre-
viously used a high dialy sate sodium bath to demon-
strate that plasma osmolality may play a role in the
stability of blood pressure during ultrafiltration [8].
A recent preliminary report, however, suggests that
constant osmolality is of less protective importance
[20]. Thus, the purpose of the present investigations
was to focus on the potential protective features of
ultrafiltration by elucidating the relationship be-
tween blood pressure and changes in osmolality and
determining the importance of changes in serum po-
tassium and plasma norepinephrine during the ma-
neuver. Additionally, the further influence of up-
right posture on blood pressure was incorporated
into each dialysis protocol as a practical means of
assessing stability. To obviate as many variables as
possible and in contrast to previous investigations
in this area [2, 7], we specifically selected six stable
normotensive patients with normal autonomic test-
ing and without prior episodes of hypotension on
dialysis. None of the patients were on anti-
hypertensive medicines, and all were studied at the
beginning of the dialysis week.
In the first series of studies, the patients under-
went a 2.5 to 3.0% weight loss over a 2-hour period,
first on regular dialysis and then on ultrafiltration
alone. Supine blood pressures after these first two
procedures and after weight loss were comparable,
but with the added stimulus of standing, important
differences were noted. Mean blood pressure fell
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significantly after the regular dilaysis procedure
(Table 4 and Fig. 2) and three of the six patients
became symptomatic. In contrast, after ultrafiltra-
tion orthostatic blood pressure did not fall, and im-
portantly, none of the patients were symptomatic.
Thus, these initial two maneuvers confirm the prior
experience with ultrafiltration [6], although the im-
portance of the upright posture had not been pre-
viously systematically studied.
In the next series of investigations, potassium
was added to the dialysate so that serum potassium
remained unchanged throughout the 2-hour course
of the procedure as weight decreased. This maneu-
ver failed to maintain blood pressure after standing,
and four of the six patients again became sympto-
matic during the orthostatic maneuver. Thus, a
stable serum potassium was insufficient as an isolat-
ed factor to account for the hemodynamic stability
observed with ultrafiltration. Plasma norepineph-
rine concentration was observed to increase signifi-
cantly on standing, but the magnitude of the in-
crease was statistically no different than in the pre-
vious two procedures.
To investigate the importance of a constant Os-
molality as a protective factor of blood pressure
during ultrafiltration, we infused hypertonic manni-
tol (25%) in a dose previously associated with a
stable osmolality during dialysis [12]. This method
of providing a constant osmolality was selected to
allow for the incorporation of a volume control in a
subsequent protocol (isotonic mannitol studies,
vide infra). In marked contrast to the results in the
isokalemic dialysis maneuver, no orthostatic de-
crease in blood pressure occurred in the patients af-
ter a 2.6% decrease in body weight, and none of the
patients became symptomatic after standing. These
results were thus comparable to those observed
during ultrafiltration alone, and occurred despite a
fall in serum potassium and no significant increase
in catecholamines. Moreover, the insignificant de-
crease (1%) in plasma osmolality was comparable to
the decrease during ultrafiltration (1%) and was sig-
nificantly less than the decrease in osmolality with
regular (7%) and isokalemic (4%) dialysis. The in-
fusion of hypertonic mannitol, however, not only
produced a constant osmolality, but also provided
expansion of the circulating plasma volume. There-
fore, a final group of studies was performed in
which the volume given in the hypertonic mannitol
studies was matched with isotonic mannitol (5%),
thereby allowing osmolality to decline (by 5.2%). In
this final group of studies, blood pressure again fell
after a 2.13% decrease in body weight and the iso-
tonic volume infusion. Importantly, increases in he-
matocrit and plasma proteins were comparable after
the mannitol infusion maneuvers, suggesting com-
parable decrements in estimated plasma volume.
Thus, the results from all of the dialysis groups
would suggest that an important mechanism by
which blood pressure is protected in ultrafiltration
is via an effect of osmolality on vascular reactivity,
lending support to the earlier conclusions made by
Bergstrom [6]. The studies with hypertonic and iso-
tonic mannitol do not conclusively exclude, how-
ever, an additional effect of osmolality on extra-
cellular fluid volume distribution, for the precise
amouit of volume flux during these procedures is
unknown. Clearly, however, maintenance of Os-
molality (no more than a 1% decrease) afforded the
greatest protection of blood pressure as pressure
still decreased following isotonic volume repletion
in the context of rapid weight loss on dialysis. Inter-
estingly, studies in experimental animals suggest
that sudden declines in osmolality (concomitant
with decrements in potassium and magnesium) pro-
duce an increase in cardiac output, a modest decline
in peripheral vascular resistance, and a resultant in-
crease in blood pressure [21, 22]. Thus, the present
results and those of Wehie et a! [8] are compatible
with an effect of declining osmolality to reduce pe-
ripheral vascular resistance, although this is a sub-
ject worthy of further investigation.
The present results clearly demonstrate that
changes in serum potassium may be dissociated
from changes in blood pressure during weight loss
and dialysis, provided no cardiac arrythmias occur.
Thus, blood pressure was maintained despite a fall
in serum potassium in one maneuver (hypertonic
mannitol), but fell when pOtassium was unchanged
in another (isokalemic dialysis).
Plasma norepinephrine concentration was again
noted to be high in these dialysis patients, but the
modest increases in catecholamines did not prevent
an orthostatic fall in blood pressure (> 10 mm Hg)
in the isokalemic and isotonic mannitol groups.
These increases in catecholamines may in part sim-
ply be a secondary increase and reflect the degree of
hypotension to which the patients were subjected.
The added stimulus of upright posture in these stud-
ies, however, demonstrates that plasma norepi-
nephrine is able to moderately increase during the
dialysis procedures, a finding not previously ob-
served.
Summary. The ultrafiltration procedure affords
orthostatic blood pressure stability during rapid
weight removal when compared with regular dial-
ysis. Maintenance of constant plasma osmolality
appears to be the major protective reason for this
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stability, probably via an effect on peripheral vascu-
lar resistance. The acute changes in blood pressure
that occur in dialysis may be dissociated from acute
changes in serum potassium concentration. Last,
although plasma norepinephrine concentrations are
high in dialysis patients, the magnitude of further
increases in norepinephrine concentrations ob-
served in these studies would appear to be in-
sufficient to protect blood pressure during the stress
of rapid weight removal and standing.
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